28.07.2011 • News

Ashland Q3 Profit Plunges On Raw Material Costs

Ashland Chairman and Chief Executive Officer James OBrien said: Our June... — Ashland Chairman and Chief Executive Officer James O'Brien said: "Our June quarter results were significantly affected by steep raw-material cost increases."

Specialty chemicals company Ashland reported Thursday its third-quarter preliminary results with net income of $87 million or $1.09 per share, lower than last year's $1.85 per share. Income from continuing operations was $69 million or $0.86 per share, compared to last year's $1.46 per share.
Adjusted earnings from continuing operations fell to $0.92 per share from $1.01 per share a year ago.

On average, nine analysts polled by Thomson Reuters expected earnings of $0.84 per share. Analysts' estimates typically exclude special items.
Ashland Chairman and Chief Executive Officer James O'Brien said, "Our June quarter results were significantly affected by steep raw-material cost increases."

However, sales increased 13% to $1.67 billion. Analysts expected sales of $1.65 billion.

Looking ahead, the company noted that its principal challenge in the near term continues to be recovery of raw-material cost increases.

Innovation Pitch

Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Virtual Event

Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.